论文信息 - Placebo-controlled phase III study comparing dexamethasone on day 1 to on day 1-3 with NK1 receptor antagonist and palonosetoron in high emetogenic chemotherapy.

Placebo-controlled phase III study comparing dexamethasone on day 1 to on day 1-3 with NK1 receptor antagonist and palonosetoron in high emetogenic chemotherapy.

10019Background: Standard antiemetic therapy for chemotherapy-induced nausea and vomiting in high emetogenic chemotherapy (HEC) is a combination of NK1 receptor antagonist, 5-HT3 receptor antagonis...